Randomized Controlled Trial of Atomoxetine for Cognitive Dysfunction in Early Huntington Disease

Overview of attention for article published in Journal of Clinical Psychopharmacology, October 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

patent: 7 patents

guideline: 1 clinical guideline source

Readers on

mendeley: 105 Mendeley

So far, Altmetric has seen 7 patents that reference this research output.

SPT5 inhibitors and uses thereof

Grant US-12661353-B2

United States of America

23 Jun 2026

Virus AAV/IGF2, genetic treatment method and use thereof in protein misfolding-related…

Grant US-12642872-B2

United States of America

02 Jun 2026

Methods for the treatment of abnormal involuntary movement disorders

Grant US-12016858-B2

United States of America

25 Jun 2024

Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular…

Grant US-11666566-B2

United States of America

06 Jun 2023

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 3 additional patents.